Ergonovine Maleate
Click to View Image
C19H23N3O2·C4H4O4 441.48

Ergoline-8-carboxamide,9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methyl-,8b(S)-,(Z)-2-butenedioate (1:1)(salt).
9,10-Didehydro-N-[(S)-2-hydroxy-1-methylethyl]-6-methylergoline-8b-carboxamide maleate (1:1)(salt) [129-51-1].
»Ergonovine Maleate contains not less than 97.0percent and not more than 103.0percent of C19H23N3O2·C4H4O4,calculated on the dried basis.
Packaging and storage— Preserve in tight,light-resistant containers,in a cold place.
Identification—
A: Infrared Absorption á197Kñ.
B: Ultraviolet Absorption á197Uñ
Solution: 20µg per mL.
Medium: alcohol.
Absorptivities at 311nm,calculated on the dried basis,do not differ by more than 3.0%.
C: The RFvalue of the principal blue spot obtained from the Test preparationcorresponds to that obtained from the Standard preparationin the chromatogram prepared as directed in the test for Related alkaloids.
Specific rotation á781Sñ: between +51and +56.
Test solution: 5mg per mL,in water.
Loss on drying á731ñ Dry it in vacuum at 80for 3hours:it loses not more than 2.0%of its weight.
Related alkaloids— [NOTE—Conduct this test promptly,without exposure to daylight and with minimum exposure to artificial light.]
Adsorbent: 0.25-mm layer of chromatographic silica gel mixture.
Solvent mixture— Prepare a mixture of alcohol and ammonium hydroxide (9:1).
Standard preparation— Prepare a solution of USP Ergonovine Maleate RSin Solvent mixturehaving a known concentration of about 10mg per mL.
Standard dilutions— Prepare a series of dilutions of the Standard preparationin Solvent mixturehaving known concentrations of about 0.20,0.10,and 0.05mg per mL.Use immediately after preparation.
Test preparation— Immediately prior to use,prepare a solution of Ergonovine Maleate in Solvent mixturehaving a concentration of about 10mg per mL.
Application volume: 5µL.
Developing solvent system: a mixture of chloroform,methanol,and water (75:25:3),equilibrated for 30minutes.
Procedure— Apply 5-µLportions of the Standard preparation,each of the three Standard dilutions,and the Test preparation,and proceed as directed for Thin-Layer Chromatographyunder Chromatography á621ñ.Locate the spots on the plate by spraying thoroughly and evenly with a solution prepared by dissolving 1g of p-dimethylaminobenzaldehyde in a cooled mixture of 50mLof alcohol and 50mLof hydrochloric acid.Immediately dry in a stream of nitrogen for about 2minutes:the RFvalue of the principal spot obtained from the Test preparationcorresponds to that obtained from the Standard preparation.Estimate the concentration of any other spots observed in the chromatogram of the Test preparationby comparison with the Standard dilutions.The spots from the 0.20,0.10,and 0.05mg per mLdilutions are equivalent to 2.0%,1.0%,and 0.50%of impurities,respectively.The sum of the impurities is not greater than 2.0%.
Assay—
Standard preparation— Using a suitable quantity of USP Ergonovine Maleate RS,accurately weighed,prepare a solution in water having a known concentration of about 40µg per mL.
Assay preparation— Transfer about 40mg of Ergonovine Maleate,accurately weighed,to a 100-mLvolumetric flask,dilute with water to volume,and mix.Dilute 10.0mLof this solution with water to 100.0mL.
Procedure— Transfer 5.0mLeach of the Standard preparation,the Assay preparation,and water to provide a blank,to separate conical flasks.Add 10.0mLof p-dimethylaminobenzaldehyde TSwith constant swirling to each,and allow to stand for 20minutes.Concomitantly determine the absorbances of the solutions in 1-cm cells at the wavelength of maximum absorbance at about 555nm,with a suitable spectrophotometer,against the blank.Calculate the quantity,in mg,of C19H23N3O2·C4H4O4taken by the formula:
C(AU/AS),
in which Cis the concentration,in µg per mL,of USP Ergonovine Maleate RSin the Standard preparation,and AUand ASare the absorbances of the solutions from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Clydewyn M.Anthony,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28–NF23Page 751
Pharmacopeial Forum:Volume No.29(5)Page 1478
Phone Number:1-301-816-8139